13508-96-8

Basic information

• Product Name: 2-Methyl-4-nitropyridine
• Synonyms: 2-METHYL-4-NITROPYRIDINE;4-NITRO-2-METHYLPYRIDINE;4-NITRO-2-PICOLINE;Pyridine, 2-methyl-4-nitro- (9CI);Pyridine, 2-methyl-4-nitro-;2-METHYL-4-NITROPYRIDINE,4-NITRO-2-PICOLINE;2-Methyl-4-nitropyridine ,97%;2-Mehtyl-4-nitropyridine
• CAS NO: 13508-96-8
• Molecular Formula: C₆H₆N₂O₂
• Molecular Weight: 138.12
• EINECS: -0
• Product Categories: NITRO;blocks;NitroCompounds;Pyridines;Pyridine;Pyridine series;Pyridines derivates;Building Blocks;Aromatics Compounds;Aromatics;Bases & Related Reagents;Nucleotides
• Mol File: 13508-96-8.mol
• Article Data: 8

Chemical Properties

• Melting Point: 32-34 °C
• Boiling Point: 241.5 °C at 760 mmHg
• Flash Point: 99.9 °C
• Appearance: yellow solid
• Density: 1.246 g/cm³
• Vapor Pressure: 0.0554mmHg at 25°C
• Refractive Index: 1.558
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• Solubility: Chloroform, Dichloromethane
• PKA: 2.04±0.10(Predicted)
• CAS DataBase Reference: 2-Methyl-4-nitropyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Methyl-4-nitropyridine(13508-96-8)
• EPA Substance Registry System: 2-Methyl-4-nitropyridine(13508-96-8)

Safety Data

• Hazard Codes: Xn
• Statements: 22-41
• Safety Statements: 26-39-24/25
• Hazardous Substances Data: 13508-96-8(Hazardous Substances Data)

Usage

Chemical Properties

Yellow Solid

Uses

2-Methyl-4-nitropyridine (cas# 13508-96-8) is a compound useful in organic synthesis.

InChI:InChI=1/C6H6N2O2/c1-5-4-6(8(9)10)2-3-7-5/h2-4H,1H3

Upstream product

• 5470-66-6 2-methyl-4-nitropyridine N-oxide 
• 67-66-3 chloroform 
• 7719-12-2 phosphorus trichloride 

Downstream Products

• 22282-99-1 4-bromo-2-methylpyridine 
• 13509-19-8 4-nitropyridine-2-carboxylic acid 
• 88912-66-7 3-Benzenesulfonylmethyl-2-methyl-4-nitro-pyridine 
• 211758-54-2 3-Benzenesulfonylmethyl-4-methoxy-2-methyl-pyridine 
• 211758-55-3 3-(1-Benzenesulfonyl-but-3-enyl)-4-methoxy-2-methyl-pyridine 
• 211758-64-4 Acetic acid 1-[2-(4-methoxy-2-phenylsulfanylmethyl-pyridin-3-yl)-ethyl]-allyl ester 
• 211758-61-1 2-Benzenesulfonylmethyl-3-[3-(tert-butyl-dimethyl-silanyloxy)-pent-4-enyl]-4-methoxy-pyridine 
• 211758-66-6 5-{4-Methoxy-2-[(E)-6-(4-methoxy-2-phenylsulfanylmethyl-pyridin-3-yl)-hex-3-enyl]-pyridin-3-yl}-pent-1-en-3-ol 
• 211758-90-6 (Z)-5-{2-[(Z)-6-(2-Benzenesulfonylmethyl-4-methoxy-pyridin-3-yl)-hex-3-enyl]-4-methoxy-pyridin-3-yl}-pent-2-en-1-ol 
• 211758-94-0 7-Benzenesulfonyl-12,24-dimethoxy-9,21-diaza-tricyclo[18.4.0.0^8,13]tetracosa-1⁽²⁰⁾,8⁽¹³⁾,9,11,21,23-hexaene 
• 211759-07-8 C₃₆H₅₀N₂O₃SSi 
• 211758-95-1 7-Allyl-7-benzenesulfonyl-12,24-dimethoxy-9,21-diaza-tricyclo[18.4.0.0^8,13]tetracosa-1⁽²⁰⁾,8⁽¹³⁾,9,11,21,23-hexaene 
• 211758-67-7 2,2-Dimethyl-propionic acid 1-(2-{4-methoxy-2-[(E)-6-(4-methoxy-2-phenylsulfanylmethyl-pyridin-3-yl)-hex-3-enyl]-pyridin-3-yl}-ethyl)-allyl ester 
• 211758-68-8 2,2-Dimethyl-propionic acid 1-(2-{2-[(E)-6-(2-benzenesulfonylmethyl-4-methoxy-pyridin-3-yl)-hex-3-enyl]-4-methoxy-pyridin-3-yl}-ethyl)-allyl ester 

Relevant articles and documents

The synthesis of 6-deazaformycin A

The synthesis of the new C-nucleoside 6-deazaformycin A was achieved through the condensation of a suitably substituted lithiated 2-picoline with 2,3,5-tri-O-benzyl-d-ribonolactone, borohydride reduction of the resulting hemiacetals, followed by intramolecular Mitsunobu cyclization of the carbinols, manipulation of the protecting groups, and subsequent ring closure to result in the formation of 7-amino-3-(β-d-ribofuranosyl)pyrazolo[4,3-b]pyridine. Georg Thieme Verlag Stuttgart.

Selective deoxygenation of heteroaromatic N-oxides with olefins catalyzed by ruthenium porphyrin

A new convenient method of deoxygenation of heteroaromatic N-oxides is described. Ruthenium porphyrin was used as a catalyst and this method expressed high yields for o-substituted pyridine N-oxides, quinoline N-oxide derivatives, acridine N-oxide, etc. under mild conditions. Moreover, nitro-, benzyloxy-, and ketone carbonyl groups, which can be affected by the usual deoxygenation methods such as catalytic hydrogenation or borane reduction, were retained.

8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection

The invention relates to novel 8-arylalkyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepines of general formula 1 which are useful in the prevention or treatment of HIV infection.